The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CAESARS ENTERTAINMENT INC NE | COM | 12769G100 | 37,506 | 505,000 | SH | DFND | 505,000 | 0 | 0 | ||
| CUMULUS MEDIA INC | COM CL A | 231082801 | 15,626 | 1,792,000 | SH | DFND | 1,792,000 | 0 | 0 | ||
| FIRSTENERGY CORP | COM | 337932107 | 52,802 | 1,725,000 | SH | DFND | 1,725,000 | 0 | 0 | ||
| GOGO INC | NOTE 6.000% 5/1 | 38046CAD1 | 6,319 | 3,750,000 | PRN | DFND | 3,750,000 | 0 | 0 | ||
| GOGO INC | COM | 38046C109 | 3,961 | 411,330 | SH | DFND | 411,330 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 45845PAA6 | 44,527 | 57,420,000 | PRN | DFND | 57,420,000 | 0 | 0 | ||
| IHEARTMEDIA INC | COM CL A | 45174J509 | 23,585 | 1,817,000 | SH | DFND | 1,817,000 | 0 | 0 | ||
| LENSAR INC | COM | 52634L108 | 7,637 | 1,053,389 | SH | DFND | 1,053,389 | 0 | 0 | ||
| PDL BIOPHARMA INC | COM | 69329Y104 | 58,745 | 23,783,273 | SH | DFND | 23,783,273 | 0 | 0 | ||
| PG&E CORP | COM | 69331C108 | 428,204 | 34,366,300 | SH | DFND | 34,366,300 | 0 | 0 | ||
| STUDIO CITY INTL HLDGS LTD | SPON ADS | 86389T106 | 182,711 | 15,392,680 | SH | DFND | 15,392,680 | 0 | 0 | ||